The Archive.
Every past brief, dated and permanent. Daily peptide research curation accumulates.
2026-08
- 2026-08-18 PETER ATTIA GOES DEEP ON PEPTIDES: PROMISE, HYPE, AND WHY REAL DRUGS DEMAND REAL RESPECT...
- 2026-08-17 PETER ATTIA GOES DEEP ON PEPTIDES: 'REAL DRUGS TREATED CARELESSLY'...
- 2026-08-16 PETER ATTIA EPISODE #403: PEPTIDES — SCIENTIFIC PROMISE VS. MARKETING HYPE...
- 2026-08-15 PETER ATTIA DRAWS THE LINE: PEPTIDES ARE REAL DRUGS — TREAT THEM THAT WAY...
- 2026-08-14 THYMULIN CUTS INFLAMMAGING MARKERS IN TUMOR-BEARING MICE — THYMUS PEPTIDE STEPS INTO THE SPOTLIGHT...
- 2026-08-13 THYMULIN CUTS AGE-RELATED INFLAMMATION IN MOUSE STUDY — IMMUNE PEPTIDE EARNS A SECOND LOOK...
- 2026-08-12 PETER ATTIA DRAWS THE LINE: PEPTIDES ARE REAL DRUGS AND DEMAND REAL RIGOR...
- 2026-08-11 PETER ATTIA DRAWS THE LINE: PEPTIDES ARE REAL DRUGS — TREAT THEM THAT WAY...
- 2026-08-10 PETER ATTIA DRAWS THE LINE: PEPTIDES ARE REAL DRUGS, TREAT THEM THAT WAY...
- 2026-08-09 HUBERMAN AND FERRISS GO DEEP ON PEPTIDES, PERFORMANCE, AND PROTOCOLS...
- 2026-08-08 HUBERMAN AND FERRISS GO DEEP ON PEPTIDES, PERFORMANCE, AND PROTOCOLS...
- 2026-08-06 HUBERMAN AND FERRISS GO DEEP ON PEPTIDES, PERFORMANCE, AND PROTOCOLS...
- 2026-08-05 VALINE RESTRICTION EXTENDS MALE MOUSE LIFESPAN BY 23% IN NEW STUDY...
- 2026-08-04 HUBERMAN AND TIM FERRISS GO DEEP ON PEPTIDES, PERFORMANCE, AND PROTOCOLS...
- 2026-08-03 HUBERMAN AND FERRISS GO DEEP ON PEPTIDES, PERFORMANCE, AND PROTOCOLS...
- 2026-08-02 FIGHT AGING! TAKES THE SKEPTIC'S SEAT ON THE PEPTIDE CRAZE — AND THE CASE IS WORTH READING...
- 2026-08-01 THE CONSERVATIVE CASE AGAINST THE PEPTIDE CRAZE — AND WHERE IT FALLS SHORT...
2026-07
- 2026-07-31 HUBERMAN AND FERRISS GO DEEP ON PEPTIDES, PERFORMANCE, AND PROTOCOLS...
- 2026-07-30 NYC WOMAN DIES AFTER NAD+ LONGEVITY INFUSION — WHAT WENT WRONG...
- 2026-07-29 NYC WOMAN DEAD AFTER 'LONGEVITY INFUSION' — NAD+ ADMINISTRATION GOES CATASTROPHICALLY WRONG...
- 2026-07-28 HUBERMAN AND FERRISS GO DEEP ON PEPTIDES, PERFORMANCE, AND PROTOCOLS...
- 2026-07-27 NYC WOMAN DIES AFTER IV NAD+ INFUSION AT LONGEVITY CLINIC...
- 2026-07-26 FDA PANEL ENDORSES BROADER ACCESS FOR BPC-157, KPV, TB-500, AND MOTS-C...
- 2026-07-25 NYC WOMAN DIES AFTER IV NAD+ INFUSION — WHAT WENT WRONG...
- 2026-07-24 HUBERMAN AND FERRISS GO DEEP ON PEPTIDES, PERFORMANCE, AND PROTOCOLS...
- 2026-07-23 HUBERMAN AND FERRISS GO DEEP ON PEPTIDES, PERFORMANCE, AND PROTOCOLS...
- 2026-07-22 REGULAR TRAINING ERASES KEY MUSCLE AGING SIGNATURES IN NEW STUDY...
- 2026-07-21 NAD+ LINKED TO MENOPAUSAL SYMPTOM RELIEF IN ELYSIUM PILOT STUDY...
- 2026-07-20 ENGINEERED ENZYME REVERSES AGE-RELATED PROTEIN DAMAGE IN LANDMARK STUDY...
- 2026-07-19 ENGINEERED ENZYME STRIPS AGE-LINKED PROTEIN DAMAGE IN LANDMARK BIOCHEMISTRY ADVANCE...
- 2026-07-18 ENGINEERED ENZYME REVERSES AGE-RELATED PROTEIN DAMAGE IN BREAKTHROUGH STUDY...
- 2026-07-17 THYMUS CLOCK SLOWED: GPR40 RECEPTOR ACTIVATION DELAYS IMMUNE AGING IN MOUSE MODEL...
- 2026-07-16 SENOLYTICS + STEM CELLS SHOW SYNERGISTIC TISSUE REPAIR IN MOUSE MODEL...
- 2026-07-15 SENOLYTICS + STEM CELLS SHOW SYNERGISTIC EFFECT IN MOUSE STUDY...
- 2026-07-14 SENOLYTICS + STEM CELLS: COMBO APPROACH OUTPERFORMS EITHER ALONE IN NEW MOUSE DATA...
- 2026-07-13 SENOLYTICS + STEM CELLS SHOW SYNERGISTIC TISSUE REPAIR IN NEW MOUSE STUDY...
- 2026-07-12 SENOLYTICS + STEM CELLS SHOW SYNERGISTIC EFFECT IN MOUSE INJURY MODELS...
- 2026-07-11 SENOLYTICS + STEM CELLS SHOW SYNERGISTIC TISSUE REPAIR IN NEW MOUSE STUDY...
- 2026-07-10 SENOLYTIC DUO DASATINIB + QUERCETIN REJUVENATES AGING KIDNEY IN MICE...
- 2026-07-09 LIFESPAN.IO: CALCIUM ION RESCUE EXTENDS MOUSE LIFESPAN WITH KNOWN ANTIDEPRESSANT...
- 2026-07-08 CALCIUM ION RESCUE EXTENDS MOUSE LIFESPAN — AND THE DRUG IS ALREADY IN CLINICS...
- 2026-07-07 INTERMITTENT FASTING ADDS 12% TO MALE MOUSE LIFESPAN IN CONTROLLED STUDY...
- 2026-07-06 EVIPEDIA BRINGS STRUCTURED EVIDENCE REVIEWS TO PEPTIDE RESEARCH — AND CALLS OUT THE GAPS...
- 2026-07-05 EVIPEDIA BRINGS STRUCTURED EVIDENCE REVIEWS TO THE PEPTIDE SPACE...
- 2026-07-04 GLP-1 RAs AND MUSCLE LOSS: PETER ATTIA BREAKS DOWN THE NEW DATA...
- 2026-07-03 GLP-1 RAS AND MUSCLE LOSS: PETER ATTIA DIGS INTO NEW DATA ON PRESERVING LEAN MASS...
- 2026-07-02 GLP-1 DRUGS AND MUSCLE LOSS: PETER ATTIA BREAKS DOWN THE NEW DATA...
- 2026-07-01 STUDY MAPS EXISTING DRUGS TO HALLMARKS OF AGING — NETWORK APPROACH FINDS LONGEVITY SIGNALS IN PROTEIN INTERACTIONS...
2026-06
- 2026-06-30 GLP-1 PATCH STARTUP RAISES $12.6M TO KILL THE WEEKLY INJECTION...
- 2026-06-29 PETER ATTIA ON GLP-1s AND MUSCLE LOSS: NEW DATA CHANGES THE CALCULUS...
- 2026-06-28 BIOLOGICAL AGING DRIVING EARLY-ONSET CANCER IN YOUNGER GENERATIONS — NEW DATA...
- 2026-06-27 CELL TYPE-SPECIFIC AGING CLOCKS NOW PREDICT ALZHEIMER'S AND CANCER ONSET...
- 2026-06-26 BIOLOGICAL AGING LINKED TO SURGE IN EARLY-ONSET CANCERS, NEW STUDY FINDS...
- 2026-06-24 BIOLOGICAL AGING DRIVES EARLY-ONSET CANCER SURGE — AND THE GAP IS WIDENING BY GENERATION...
- 2026-06-23 LATE-LIFE FGF21 GENE THERAPY EXTENDS MOUSE MEDIAN LIFESPAN BY 20%...
- 2026-06-22 LATE-LIFE GENE THERAPY ADDS 20% TO MOUSE LIFESPAN — FGF21 DELIVERY IMPROVES METABOLIC MARKERS...
- 2026-06-21 LATE-LIFE GENE THERAPY ADDS 20% TO MOUSE LIFESPAN — FGF21 PROTEIN DELIVERY REWRITES METABOLIC AGING TIMELINE...
- 2026-06-20 LATE-LIFE GENE THERAPY BOOSTS MOUSE LIFESPAN BY 20% — FGF21 DELIVERY VIA MUSCLE-TARGETED VIRAL VECTOR...
- 2026-06-11 PEPTIDES AND CANCER: RESEARCH VIALS PUBLISHES THREE-PART DEEP DIVE ON TUMOR BIOLOGY, GH SECRETAGOGUES, AND RISK STRATEGY...
- 2026-06-10 LIFE BIO DOSES FIRST PATIENT IN OSK EPIGENETIC REPROGRAMMING TRIAL FOR AGE-RELATED VISION LOSS...
- 2026-06-09 WORLD-FIRST CELLULAR REJUVENATION THERAPY ADMINISTERED TO A HUMAN PATIENT...
- 2026-06-07 GROWTH HORMONE FALLS SHORT FOR ADULT TISSUE REPAIR — ATTIA DISSECTS THE EVIDENCE...
- 2026-06-06 GROWTH HORMONE AND MUSCULOSKELETAL REPAIR: PETER ATTIA WEIGHS THE EVIDENCE...
- 2026-06-05 GROWTH HORMONE FOR MUSCULOSKELETAL REPAIR: PETER ATTIA SAYS THE MECHANISM DOESN'T MATCH THE RESULTS...
- 2026-06-04 NEWLIMIT RAISES $435M TO PUSH AGE-REPROGRAMMING THERAPY INTO HUMAN TRIALS...
- 2026-06-03 PETER ATTIA: GROWTH HORMONE FOR MUSCULOSKELETAL REPAIR — WHY THE DATA STILL DISAPPOINTS...
- 2026-06-02 ELYSIUM HEALTH LAUNCHES PHYSICIAN-LED LONGEVITY INSTITUTE — PEPTIDES NOW BUNDLED INTO CLINICAL CARE...
- 2026-06-01 ELYSIUM LONGEVITY INSTITUTE LAUNCHES PHYSICIAN-LED PEPTIDE PROGRAM...
2026-05
- 2026-05-31 HARVARD DROPS PUBLIC-FACING LONGEVITY REPORT — MAINSTREAM MEDICINE FINALLY CATCHES UP...
- 2026-05-30 GROWTH HORMONE FALLS SHORT FOR ADULT TISSUE REPAIR — PETER ATTIA BREAKS DOWN THE DATA...
- 2026-05-29 GROWTH HORMONE FALLS SHORT FOR ADULT MUSCULOSKELETAL REPAIR — ATTIA UNPACKS THE EVIDENCE...
- 2026-05-27 PETER ATTIA CHALLENGES GROWTH HORMONE HYPE: MUSCULOSKELETAL REPAIR DATA FALLS SHORT...
- 2026-05-26 PETER ATTIA: GROWTH HORMONE FALLS SHORT FOR ADULT MUSCULOSKELETAL REPAIR...
- 2026-05-25 MITOCHONDRIAL AGING TIED TO LOSS OF KEY MEMBRANE LIPID — SUPPLEMENTATION HELPS IN WORMS...
- 2026-05-23 CELLULAR SENESCENCE HETEROGENEITY MAPPED — PRIMARY VS SASP-INDUCED CELLS DIFFER SHARPLY...
- 2026-05-22 PETER ATTIA DRAWS THE LINE ON PEPTIDE HYPE — AND WHERE THE REAL SCIENCE LIVES...
- 2026-05-20 GLP-1 DRUGS DON'T STEAL YOUR MUSCLE — NEW STUDY FINDS WEIGHT-LOSS MECHANISM IS THE ISSUE, NOT THE DRUG...
- 2026-05-19 GLP-1 DRUGS DON'T STEAL MUSCLE — NEW STUDY FINDS WEIGHT LOSS IS THE VARIABLE...
- 2026-05-18 GLP-1 DRUGS DON'T STEAL YOUR MUSCLE — NEW DATA CHALLENGES THE NARRATIVE...
- 2026-05-16 PETER ATTIA CALLS PEPTIDES 'LEGITIMATE BUT NARROW' IN WIDE-RANGING AMA...
- 2026-05-15 PETER ATTIA CALLS OUT PEPTIDE HYPE — AND NAMES WHAT ACTUALLY HOLDS UP...
- 2026-05-14 GLP-1 DRUGS DON'T CANNIBALIZE MUSCLE ANY MORE THAN PLAIN CALORIC RESTRICTION, NEW DATA SHOWS...
- 2026-05-13 PETER ATTIA CALLS PEPTIDES 'LEGITIMATE BUT NARROW' IN DEEP-DIVE AMA...
- 2026-05-12 PETER ATTIA BREAKS DOWN PEPTIDE SCIENCE: LEGITIMATE THERAPEUTICS OR OVERHYPED COMPOUNDS?...
- 2026-05-11 PETER ATTIA CALLS PEPTIDES 'LEGITIMATE BUT NARROW' — FULL AMA BREAKDOWN...
- 2026-05-10 PETER ATTIA GOES DEEP ON PEPTIDE SCIENCE: SEPARATING SIGNAL FROM HYPE...
- 2026-05-09 PETER ATTIA ON PEPTIDES: 'LEGITIMATE, POWERFUL CLASS OF THERAPEUTICS — BUT CONFINED TO A NARROW SUBSET'...
- 2026-05-08 PETER ATTIA ON PEPTIDES: 'LEGITIMATE BUT NARROWER THAN THE HYPE SUGGESTS'...
- 2026-05-07 CREATINE + POWER TRAINING SHOW SYNERGISTIC GAINS IN OLDER ADULTS...
- 2026-05-06 DARK PROTEOME MAPPED: THOUSANDS OF MINI-PROTEINS FOUND — INCLUDING CANCER-SPECIFIC TARGETS...